Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers
Original Report
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock’s biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with...
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock’s biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.’s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company’s adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker’s forecast sales for the second quarter missed the average analyst estimate. (Source: Bloomberg)
Glass House Analysis
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Jim Cramer says buy Target on any pullback as turnaround takes hold
Wall Street cheered improving financial metrics across the board in its latest earnings results.
Think you need a lot of money to start investing? Here are 8 apps that let you start small
Starting small can be a smart way to invest. These 8 apps let you put your money to work, even on a tight budget.
Hedge funds are about to jump into prediction markets in a big way
Cantor Fitzgerald will be one of the first investment firms providing its clients institutional trading on prediction market platform Kalshi.
Stocks, bonds and gold rally after Treasury indicates it will buy more government bonds to stop yields from surging
“The market took this as a significant intervention,” said Jill Cetina, former vice president for bank supervision at the Dallas Fed.